Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NY › Utica › NPI 1851402127
Physician

Advanced Physical Medicine & Rehabilitation LLC

Advanced Physical Medicine & Rehabilitation LLC was paid $1.07M by Medicaid between Jan 2018 and Nov 2024, across 31 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 29% of everything it billed.

33Billing provider infoADVANCED PHYSICAL MEDICINE & REHABILITATION LLC
UTICA, NY 13502
33aNPI1851402127assigned 08/31/2006
28Total paid$1.07M
24GClaims12,796
24DCodes billed31
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other Diagnostic Radiology Physician providers in New York

Rank by total paid#43 of 1,568
Median peer was paid$5K
This provider vs. median198×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$20K$40K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20181,717$189K
20192,769$222K
20201,902$112K
20211,768$149K
20221,733$136K
20231,269$107K
2024incomplete1,638$156K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 29% 3,154 3,005 $308K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 27% 4,320 4,104 $290K
95913 14% 567 483 $151K
95886 9.0% 577 493 $96K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 6.7% 379 375 $71K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 5.4% 995 985 $58K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 4.8% 659 577 $51K
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 2.3% 160 160 $25K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 1.4% 740 644 $15K
62323 <1% 25 25 $2K
77002 <1% 15 12 $1K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 202 159 $892.54
19 more codes
80336 <1% 54 $804.20
76942 <1% 13 $675.18
80361 <1% 54 $527.00
80348 <1% 54 $507.16
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 68 $45.11
80346 <1% 54 $32.22
80364 <1% 54 $15.93
80356 <1% 54 $15.90
80365 <1% 54 $14.18
80358 <1% 54 $13.12
80353 <1% 54 $12.20
80337 <1% 42 $10.35
80359 <1% 54 $10.12
94761 <1% 63 $3.68
99000 0% 80 $0.00
80324 0% 42 $0.00
80335 0% 54 $0.00
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 0% 38 $0.00
A4550 Surgical trays 0% 63 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHAIDER, NAMEER (AUTHORIZED SIGNATORY)
Same official

Other billing entities under HAIDER, NAMEER

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.